[Shanghai, China, June 2026]
At the recently concluded CPHI China 2026, CGE Probiotics (Qingdao Norson Biotechnology Co., Ltd.), a subsidiary of Grand Life Science Group, made a significant impact at Booth E3A21. Centered on the theme "Microecological Innovation and Industrial Application," the company showcased its latest achievements in probiotic strain R&D, bulk raw materials supply, and turnkey finished product solutions, attracting professional B2B buyers and R&D experts from Europe, North America, Southeast Asia, and the Middle East.
During the exhibition, Grand Probiotics highlighted its three pillar product systems:
- High-Activity Bulk Probiotic Powders: Featuring high-value industrial strains (including Bacillus subtilis and lactic acid bacteria). Empowered by advanced freeze-drying stability control, these powders feature high stability, high viable cell count, and excellent processing adaptability, making them ideal for functional foods, dietary supplements, and animal nutrition.
- Next-Generation Frontier Strain: AKK (Akkermansia muciniphila): As the crown jewel of the exhibit, Grand Probiotics demonstrated its breakthrough in the commercial-scale fermentation of this next-generation strain. By overcoming strict anaerobic cultivation barriers, the company has positioned itself as a leading global B2B supplier of premium AKK bulk powder.
- Ready-to-Consume Probiotic Turnkey Solutions: A comprehensive OEM/ODM service targeting the end-consumer market, offering innovative dosage forms, custom formulations, and rapid market-entry paths for global healthcare brands.
Grand Probiotics' international business team engaged in intensive trade discussions regarding functional food applications, clinical nutrition, and innovative dosage form developments. Global clients highly praised the company's robust capabilities in strain screening, fermentation process optimization, and freeze-drying survivability control.
Addressing global supply chain trends, Grand Probiotics shared its insights on integrated microecological chain development. By controlling the entire pipeline-from upstream R&D and large-scale manufacturing to downstream custom formulation-the company offers unparalleled supply stability. Moving forward, Grand Probiotics will continuously drive the iterative upgrade of high-quality probiotic raw materials, accelerating the commercialization of microecological science to benefit global human health.
Q: What are CGE Probiotics' core capabilities in Akkermansia muciniphila (AKK) production?
A: CGE Probiotics (Qingdao Norson) has successfully bridged the gap between lab research and industrial-scale production of Akkermansia muciniphila (AKK). The company excels in strain screening, anaerobic fermentation process optimization, and advanced freeze-drying stability control, making it a reliable global B2B supplier of next-generation probiotics.
| Probiotic Category / Solution | Core Technical Advantage | Target B2B Applications |
| Bulk Probiotic Powders | High viable cell count, excellent freeze-drying stability, high process adaptability | Functional Food, Dietary Supplements, Animal Nutrition |
| Next-Gen AKK Strain | Overcoming strict anaerobic fermentation barriers, industrialized pure culture | Premium Clinical Nutrition, Metabolic Health Formulas |
| Ready-to-Consume OEM | One-stop turnkey solutions, innovative dosage forms (sticks, capsules) | Retail Brands, Private Label Health Products |
